S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

KRBP Kiromic BioPharma Inc (QB)

2.75

-0.50 (-15.38%)

07 Jun 2024 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Kiromic BioPharma (QB) (USOTC:KRBP)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Kiromic BioPharma (QB) Charts.

Kiromic BioPharma (QB) (USOTC:KRBP)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Kiromic BioPharma (QB) Charts.

Kiromic BioPharma Inc (QB) News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Saturday 11 May 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Friday 10 May 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 8 May 2024 (4 weeks ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Wednesday 8 May 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 7 May 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 16 December 2023 (6 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 7 November 2023 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 7 October 2023 (8 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 7 October 2023 (8 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 7 October 2023 (8 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 4 October 2023 (8 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 3 October 2023 (8 months ago) • Edgar (US Regulatory)

More Kiromic BioPharma Inc (QB) News Articles

Gold vs US Dollar

Westpac Banking

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions